Loading...

24/7 Case Review: 210-940-9440
Call Now Free Case Evaluation
Hearing Exam
Warning: Permanent Damage

Tepezza Infusions Linked to
Permanent Hearing Loss.

Manufacturer Horizon Therapeutics failed to warn patients that the Thyroid Eye Disease drug Tepezza could cause permanent deafness and severe tinnitus.

The Case Against Horizon

  • Drug Type: Infusion (Teprotumumab)
  • Primary Injury: Hearing Loss & Tinnitus
  • Litigation Status: MDL 3032 Formed

*Studies indicate up to 65% of patients affected.

Why is Tepezza Dangerous?

Tepezza is the first FDA-approved drug for Thyroid Eye Disease (TED). While effective for eye symptoms, post-market studies revealed a shocking side effect: permanent hearing damage.

A 2021 study by the Endocrine Society found that 65% of patients experienced hearing issues, far higher than the 10% reported by the manufacturer during clinical trials. Lawsuits allege Horizon Therapeutics prioritized profits over patient safety by failing to update warning labels until forced to in 2023.

Who Qualifies for a Lawsuit?

  • Treatment: Received Tepezza infusions for Thyroid Eye Disease (Graves' Disease).
  • Symptoms: Experienced hearing loss, tinnitus (ringing), or hyperacusis (sensitivity to sound).
  • Diagnosis: Diagnosed by an audiologist or ENT after starting treatment.

Specific Hearing Injuries

Permanent Deafness

Partial or total loss of hearing requiring aids.

Tinnitus

Constant ringing, buzzing, or hissing in ears.

Hyperacusis

Extreme sensitivity to normal environmental sounds.

Autophony

Hearing one's own voice/breathing unusually loud.

Fact: In July 2023, the FDA mandated a label change for Tepezza to warn about the risk of permanent hearing impairment.

Estimated Settlement Tiers

Settlements aim to cover the cost of hearing aids, medical treatment, and the significant impact on quality of life.

Tier 3

$50,000 - $150,000

Temporary hearing loss that resolved after stopping treatment, or mild tinnitus.

Most Cases

Tier 2

$150,000 - $300,000

Permanent partial hearing loss requiring hearing aids, or severe, documented tinnitus.

Tier 1

$300,000 - $500,000+

Profound/Total hearing loss, cochlear implants required, significant impact on daily life/career.

Latest Tepezza Litigation News

Updates on MDL 3032 (Northern District of Illinois).

Gavel Court Update
Oct 05, 2024

Tepezza MDL Judge Sets Bellwether Schedule

Judge Thomas Durkin has issued a scheduling order for the first bellwether trials, which are expected to begin in early 2025. Discovery is now focused on Horizon's internal communications.

Read Article →
Lab Research Study Results
Sep 01, 2024

Study Finds Tepezza Hearing Loss Rates Much Higher Than Label Claims

New research confirms that up to 65% of patients suffer otologic symptoms, contradicting the 10% rate originally claimed by the manufacturer.

Read Article →
Hearing Aid FDA Action
July 25, 2024

FDA Mandates New Warning Label for Tepezza

Following mounting evidence of irreversible hearing damage, the FDA has required Horizon Therapeutics to add a specific warning about permanent hearing impairment.

Read Article →

Start Your Claim

If you suffered hearing loss after Tepezza infusions, you may be eligible for compensation for hearing aids and medical care.

No Upfront Cost
Confidential Review
Defective Drug Experts

By clicking, you agree to our Terms & Privacy Policy.

Check Your Eligibility

Our legal network reviews claims for all active litigations listed on this site. 100% Free & Confidential.

210-940-9440

Secure Evaluation

We match you with independent attorneys specializing in your specific injury type.

Legal Case Assistant Chatbot
Julia A. Hinckley

Hello there!

I'm Julia, your Legal Case Assistant. Would you like to check if you qualify for a free case evaluation?

Julia
Hi there! I can evaluate your case instantly!
The information you provide is confidential.
Julia A. Hinckley

Julia A. Hinckley

Free Case Evaluation
. . .